These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8615716)
41. [Allergic and immunologic indices in chemoprophylaxis of experimental tuberculosis]. Batiashvili OG; Gogebashvili NV Probl Tuberk; 1969; 47(10):68-73. PubMed ID: 5375702 [No Abstract] [Full Text] [Related]
42. Preventive therapy for tuberculous infection: an intervention in need of improvement. Snider DE; Farer LS Am Rev Respir Dis; 1984 Sep; 130(3):355-6. PubMed ID: 6476585 [No Abstract] [Full Text] [Related]
43. A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail. White MC; Tulsky JP; Reilly P; McIntosh HW; Hoynes TM; Goldenson J Int J Tuberc Lung Dis; 1998 Jun; 2(6):506-12. PubMed ID: 9626609 [TBL] [Abstract][Full Text] [Related]
45. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis. Alaei K; Alaei A; Mansouri D East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452 [TBL] [Abstract][Full Text] [Related]
46. Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy? Lawn SD; Wood R Int J Tuberc Lung Dis; 2012 Aug; 16(8):995-6. PubMed ID: 22762421 [No Abstract] [Full Text] [Related]
47. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans. Turner MT N Engl J Med; 1998 Mar; 338(12):841-2. PubMed ID: 9508640 [No Abstract] [Full Text] [Related]
48. Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence. Falagas ME; Voidonikola PT; Angelousi AG Int J Antimicrob Agents; 2007 Dec; 30(6):477-86. PubMed ID: 17913470 [TBL] [Abstract][Full Text] [Related]
49. Prophylaxis of mycobacterial infections in immunocompromised patients. Krance MB; Fisher MA Am Fam Physician; 1996 Nov; 54(6):1981-8, 1991-2. PubMed ID: 8900358 [TBL] [Abstract][Full Text] [Related]
50. It is too early to discount the contribution of isoniazid to the treatment of tuberculous meningitis. Seaworth BJ J Infect Dis; 2005 Jul; 192(1):10-2. PubMed ID: 15942887 [No Abstract] [Full Text] [Related]
51. Few HIV patients tested for tuberculosis. AIDS Read; 2008 Nov; 18(11):551-2. PubMed ID: 19065699 [No Abstract] [Full Text] [Related]
53. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis. Gourevitch MN; Alcabes P; Wasserman WC; Arno PS Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818 [TBL] [Abstract][Full Text] [Related]
54. [What does tuberculosis prophylaxis bring in HIV infections?]. Ronge R Dtsch Med Wochenschr; 1999 Mar; 124(10):A8-9. PubMed ID: 10215429 [No Abstract] [Full Text] [Related]
55. Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime. Nolan CM Am J Respir Crit Care Med; 2003 Aug; 168(4):412-3. PubMed ID: 12912731 [No Abstract] [Full Text] [Related]
56. Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. Munseri PJ; Talbot EA; Mtei L; Fordham von Reyn C Int J Tuberc Lung Dis; 2008 Sep; 12(9):1037-41. PubMed ID: 18713501 [TBL] [Abstract][Full Text] [Related]
57. [Molecular medicine and treatment of tuberculosis]. Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966 [No Abstract] [Full Text] [Related]